Open Orphan PLC - Publication of positive results
ORPH Wed, 11 Mar 2020, 07:00am GMT
Open Orphan was founded in 2017, with the goal of becoming Europe’s leading rare disease and orphan drug focused pharma services company by a management team with extensive industry and financial expertise.
Industry: Health Care
Contact: +353 (01) 6440007
Dublin 2, Ireland
Cathal Friel, Executive Chairman of Open Orphan and Doctor Andrew Catchpole, Chief Scientist at hVIVO discuss the publication of positive results of a Phase IIb field study of FLU-v 003 and it's significance as well as the new hVIVO contract signed with a European Biotech Company.